CYCLOSPORINE IN THE TREATMENT OF CORTICOSTEROID RESISTANT AUTOIMMUNE CHRONIC ACTIVE HEPATITIS

被引：52
作者：
JACKSON, LD
SONG, E
机构：
[1] UNIV WITWATERSRAND,DEPT MED,DIV GASTROENTEROL,JOHANNESBURG 2001,SOUTH AFRICA
[2] UNIV WITWATERSRAND,DEPT MED,DIV HEPATOL,JOHANNESBURG 2001,SOUTH AFRICA
来源：
GUT | 1995年 / 36卷 / 03期
基金：
美国国家科学基金会;
关键词：
CYCLOSPORINE; HEPATITIS; CORTICOSTEROID RESISTANCE;
D O I：
10.1136/gut.36.3.459
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
A 17 year old Asian patient with autoimmune chronic active hepatitis resistant to treatment with high dose corticosteroids and azathioprine was given cyclosporin at a dose of 5 mg/kg/day. Within two weeks of starting the cyclosporin treatment a favourable clinical and biochemical response was obtained and by one month serum aminotransferase activities were within normal limits. An attempted reduction in the daily dose of cyclosporin resulted in a relapse of the patient's disease. Remission was again attained by returning the dose of cyclosporin to 5 mg/kg/day. No significant side effects of the treatment have been shown. Cyclosporin seems to have a role in the treatment of corticosteroid resistant autoimmune chronic active hepatitis and its further evaluation is warranted.
引用
收藏
页码：459 / 461
页数：3
相关论文
共 30 条
  • [1] LIMITED DURATION OF REMISSION OF INSULIN DEPENDENCY IN CHILDREN WITH RECENT OVERT TYPE-I DIABETES TREATED WITH LOW-DOSE CYCLOSPORINE
    BOUGNERES, PF
    LANDAIS, P
    BOISSON, C
    CAREL, JC
    FRAMENT, N
    BOITARD, C
    CHAUSSAIN, JL
    BACH, JF
    [J]. DIABETES, 1990, 39 (10) : 1264 - 1272
  • [2] CYCLOSPORIN-A MEDIATES IMMUNOSUPPRESSION OF PRIMARY CYTO-TOXIC T-CELL RESPONSES BY IMPAIRING THE RELEASE OF INTERLEUKIN-1 AND INTERLEUKIN-2
    BUNJES, D
    HARDT, C
    ROLLINGHOFF, M
    WAGNER, H
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (08) : 657 - 661
  • [3] AUTOSENSITIZATION OF LYMPHOCYTES AGAINST THYMUS RETICULUM CELLS
    COHEN, IR
    WEKERLE, H
    [J]. SCIENCE, 1972, 176 (4041) : 1324 - &
  • [4] CONTROLLED PROSPECTIVE TRIAL OF CORTICOSTEROID THERAPY IN ACTIVE CHRONIC HEPATITIS
    COOK, GC
    MULLIGAN, R
    SHERLOCK, S
    [J]. QUARTERLY JOURNAL OF MEDICINE, 1971, 40 (158): : 159 - +
  • [5] CZAJA AJ, 1986, SEMIN LIVER DIS, V4, P1
  • [6] DAVIS GL, 1986, CHRONIC ACTIVE HEPAT, P26
  • [7] CYCLOSPORINE FOR PLAQUE-TYPE PSORIASIS - RESULTS OF A MULTIDOSE, DOUBLE-BLIND TRIAL
    ELLIS, CN
    FRADIN, MS
    MESSANA, JM
    BROWN, MD
    SIEGEL, MT
    HARTLEY, AH
    ROCHER, LL
    WHEELER, S
    HAMILTON, TA
    PARISH, TG
    ELLISMADU, M
    DUELL, E
    ANNESLEY, TM
    COOPER, KD
    VOORHEES, JJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (05) : 277 - 284
  • [8] RISK-FACTORS FOR CYCLOSPORINE-INDUCED NEPHROPATHY IN PATIENTS WITH AUTOIMMUNE-DISEASES
    FEUTREN, G
    MIHATSCH, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (25) : 1654 - 1660
  • [9] HANDSCHUMACHER RE, 1985, PHARMACOL BASIS THER, P1459
  • [10] CYCLOSPORINE TREATMENT OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
    HYAMS, JS
    BALLOW, M
    LEICHTNER, AM
    [J]. GASTROENTEROLOGY, 1987, 93 (04) : 890 - 893
123